Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
The oral microbiome is a galactic microcosm that is both a gateway and a mirror to the rest of the human body. Comprised of over 700 prevalent taxa at the species level with distinct subsets predominating in different habitats, the oral cavity is residence to diverse communities of bacteria, fungi, and viruses.
Balance and imbalance between microbial communities can influence the body’s state of health and disease, including heart and lung disease, cancer and various autoimmune diseases. As advances in big data analytics, next generation sequencing, and systems immunology fuel our understanding of the human microbiome, our approach toward oral health and systemic immunity simultaneously evolve.
With incidence of chronic disease on the rise, this talk will explore the latest research on the oral microbiome as a reservoir for disease pathogenesis and also a target for therapeutic intervention.